Viatris Inc. Profile Avatar - Palmy Investing

Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Drug Manufacturers - Specialty & Generic
US, Canonsburg [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2015 - 4.335 - 9,662 - 836 - 2,270 - 1,450 - 2,169
2016 - 4.739 - 10,987 - 5,719 - 2,910 - 797 - 2,877
2017 - 4.533 - 11,945 - 714 - 3,331 - 1,479 - 2,647
2018 - 4.636 - 11,392 - 350 - 3,026 - 920 - 2,516
2019 - 4.312 - 11,530 - 23 - 2,518 - 669 - 2,400
2020 0.0326 4.562 11,500 12,287 16 5,505 650 3,254 694 892 2,563 3,217
2021 -1.1100 3.715 11,946 17,888 -669 -1,130 2,102 4,015 -103 -36 3,344 4,121
2022 -1.0500 3.395 17,886 16,372 -1,269 66 301 4,542 295 811 4,529 4,204
2023 1.7100 2.962 16,262 15,472 2,078 -646 3,446 4,996 1,655 892 4,179 4,624
2024 0.0456 2.674 15,381 14,819 54 3,226 4,732 3,925 2,053 1,076 3,721 3,880
2025 - 2.688 - 14,426 - 3,213 - 3,820 - 1,047 - 3,777
2026 - 2.755 - 14,465 - 1.F11X/td> - 1.F111/td> - 1.F111 - 1.F111
2027 - 2.740 - 16,564 - 0.F12X/td> - 0.F121/td> - 0.F121 - 0.F121
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-16.081% $2.15 · MISS

Nov. 6, 2024
Price Then
$11.61
Price Target
$15.52
Price Now
$13.37
End of VTRS's Analysis
CIK: 1792044 CUSIP: 92556V106 ISIN: US92556V1061 LEI: - UEI: -
Secondary Listings
VTRS has no secondary listings inside our databases.